DealBio
All collections

Investor Intelligence

10 Neurotechnology Investors in Europe

European investors with demonstrated activity across neural interfaces, brain-computer interfaces, bioelectronic devices and brain-focused therapeutics.

Published
  • Neurotechnology
  • Neural Interfaces
  • Brain-Computer Interfaces
  • Europe
  • Seed
  • Series A

investing spans hardware, software and therapeutics. Recent European activity includes implantable neural interfaces, brain-signal communication systems and precision approaches to neurological and neuropsychiatric disease, with investors entering from both deep tech and specialist life sciences.

DealBio selected 10 investors with evidenced relevance to neurotechnology in Europe, using current investor research, financing precedents and public verification where needed.

Artesian VC

Global early-stage venture investor backing frontier technology and deep-tech companies.

Stage
Seed
Sector / Focus
Neurotechnology · Neural interfaces · Medical devices
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

Artesian co-led Coherence Neuro’s $10 million seed round in 2025. Coherence is developing SOMA-1, an implantable designed to monitor disease-related electrical signals and deliver , giving Artesian a direct therapeutic-neurotechnology precedent.

Blackbird Ventures

Early-stage venture firm investing in ambitious technology companies.

Stage
Seed
Sector / Focus
Neurotechnology · Neural interfaces · Medical devices
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

Blackbird led Coherence Neuro’s pre-seed round and continued into its $10 million seed financing. Coherence is developing a miniature implantable neural interface for monitoring and electrical stimulation, providing Blackbird with repeated exposure to therapeutic neurotechnology.

Possible Ventures

Early-stage venture firm backing science and technology companies.

Stage
Seed
Sector / Focus
Neurotechnology · Neural interfaces
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

Possible Ventures backed Coherence Neuro at pre-seed and continued into its $10 million seed round. The company’s implantable neural interface combines sensing, stimulation and software for closed-loop therapeutic use.

Divergent Capital

Early-stage investor focused on deep technology and technically ambitious startups.

Stage
Seed
Sector / Focus
Neurotechnology · Neural interfaces
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

Divergent Capital participated in Coherence Neuro’s $10 million seed round. Coherence is developing implantable bioelectronic technology that reads electrical signals and delivers targeted stimulation, making the investment directly relevant to neural devices.

Jumpspace Ventures

Early-stage venture investor backing technology companies.

Stage
Seed
Sector / Focus
Neurotechnology · Neural interfaces
Investment markets
United Kingdom
Investor type
VC

Relevant investment

Jumpspace Ventures joined Coherence Neuro’s $10 million seed financing. The company’s SOMA-1 implant is designed as a closed-loop neural interface, combining disease monitoring with electrical stimulation.

SmartGateVC

Early-stage venture fund investing in technology and science-led companies.

Stage
Seed
Sector / Focus
Neurotechnology · Neural interfaces
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

SmartGateVC participated in Coherence Neuro’s seed financing. Coherence’s platform combines an implantable neural device, wearable electronics and software to support closed-loop therapeutic stimulation.

Spacewalk VC

Early-stage venture investor backing frontier technology companies.

Stage
Seed
Sector / Focus
Neurotechnology · Neural interfaces
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

Spacewalk VC joined Coherence Neuro’s $10 million seed round. The investment provides direct exposure to implantable neural interfaces and .

Xtal Ventures

Early-stage venture investor supporting science-driven technology companies.

Stage
Seed
Sector / Focus
Neurotechnology · Neural interfaces
Investment markets
United Kingdom · Europe
Investor type
VC

Relevant investment

Xtal Ventures participated in Coherence Neuro’s $10 million seed financing. Coherence is advancing an implantable system designed to sense biological signals and deliver electrical stimulation in a closed loop.

Utrecht Holdings Seed Fund

University-linked seed investor supporting life-sciences and deep-tech spinouts.

Stage
Pre-seed · Seed
Sector / Focus
Neurotechnology · Brain-computer interfaces
Investment markets
The Netherlands
Investor type
Seed fund

Relevant investment

Utrecht Holdings Seed Fund backs UCANACT, a Dutch brain-computer-interface company developing communication technology from brain signals. The investment gives the fund direct exposure to neural decoding and assistive neurotechnology.

Forbion

European life-sciences VC investing across biotechnology from company formation through growth.

Stage
Series A · Growth
Sector / Focus
CNS therapeutics · Neurotechnology · Brain disease
Investment markets
Europe
Investor type
VC

Relevant investment

Forbion has direct brain-disease exposure through companies including VectorY and Kynexis. VectorY develops vectorised antibody therapies for neurodegenerative disease, while Kynexis is advancing a precision therapeutic for cognitive impairment associated with schizophrenia.

Methodology

DealBio builds investor lists using structured investor research, demonstrated investment activity and current public verification where needed. The methodology highlights investors with evidenced relevance to the article’s sector, stage and geography.

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.